-
Results That MatterCancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.
by Eric Fitzsimmons
-
April 5: The Week in Cancer NewsMore cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage breast cancers.
by Marci A. Landsmann
-
Genetic Testing for Women With Breast CancerNew recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
by Laura Gesualdi-Gilmore
-
March 29: The Week in Cancer NewsSurvival rates have increased for older AML patients who receive stem cell transplants, and cervical cancer diagnoses rise among women living in low-income counties.
by Kevin McLaughlin
-
TIL Therapy Amplifies the Immune System’s Attack on MelanomaThe recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
March 22: The Week in Cancer NewsFirst CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos use in manufacturing.
by Thomas Celona
-
Dealing With Immediate Medical Test ResultsPatients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.
by Taneia Surles
-
March 15: The Week in Cancer NewsModified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.
by Eric Fitzsimmons
-
Empowering Pediatric Cancer PatientsAfter twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
-
March 8: The Week in Cancer NewsWhy do many Asian American women who have never smoked have lung cancer, and a report finds acne products can create cancer-causing benzine.
by Marci A. Landsmann
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
